Brief: Hemostemix Announces Corporate Update
11/12/2019 12:42
Dec 11 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX ANNOUNCES CORPORATE UPDATE
* HEMOSTEMIX INC - ANNOUNCES APPOINTMENT OF DAVID WOOD TO
POSITION
OF CHAIRMAN, BRYSON GOODWIN TO POSITION OF CHIEF EXECUTIVE
OFFICER
* HEMOSTEMIX INC - ANNOUNCES APPOINTMENT OF THOMAS SMEENK TO
POSITION OF PRESIDENT, AND NATASHA SEVER TO POSITION OF CFO
* HEMOSTEMIX INC - HAS RESCINDED AMENDED AND RESTATED
LICENSE
AGREEMENT GRANTED TO ASPIRE HEALTH SCIENCE, LLC DATED SEPTEMBER
30
Source text for Eikon: ID:nGNX8wXtjc
Further company coverage: HEM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update